Cipla informs about informs about company updates

20 Jul 2019 Evaluate

Cipla has informed that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection at its API manufacturing facility in Virgonangar, Bengaluru, from 15th June, 2019 to 19th June, 2019. The inspection ended with 7 observations, none of which were repeat or related to data integrity. The Company will respond to the agency within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1351.85 4.20 (0.31%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×